The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Barchart on MSN
Should You Buy the Dip in Intellia Therapeutics Stock?
In biotech, success often begins in the lab — and for CRISPR pioneers, every clinical trial feels like a moonshot.
Find out why HDFN should not go untreated, even if it's a mild case, as untreated hemolytic disease can have lasting effects.
Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...
After a powerhouse performance in 'Better Call Saul,' Rhea Seehorn returns to television as the most miserable woman in the ...
Scientists have uncovered a new environmental culprit behind liver disease: tetrachloroethylene (PCE), a chemical used in dry ...
The market for at-home gut microbiome tests is booming, with companies promising insights into health, chronic illness and ...
News-Medical.Net on MSN
Understanding thrombocytopenia in patients with portal hypertension and chronic liver disease
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results